Oppenheimer & Co’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Oppenheimer & Co’s Portfolio IBDW Stock Details IBDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$958K	Sell	45,781 -1,466	-3%	-$31K	0.01%	878
2025 Q4	$999K	Buy	47,247 +2,776	+6%	+$58.8K	0.01%	801
2025 Q3	$944K	Buy	44,471 +87	+0.2%	+$1.83K	0.01%	918
2025 Q2	$934K	Buy	44,384 +1,582	+4%	+$32.7K	0.01%	883
2025 Q1	$888K	Buy	42,802 +2,421	+6%	+$49.7K	0.01%	853
2024 Q4	$822K	Buy	40,381 +915	+2%	+$18.9K	0.01%	876
2024 Q3	$837K	Buy	39,466 +29,393	+292%	+$613K	0.01%	852
2024 Q2	$204K	Buy	+10,073	New	+$203K	﹤0.01%	1330

Other funds holding IBDW

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.22B AUM 22.28% 1-Year Est. Return

VVP

Venture Visionary Partners Sylvania, Ohio $3B AUM 24.41% 1-Year Est. Return

SVWA

Sarver Vrooman Wealth Advisors Kansas City, Missouri $168M AUM 7.75% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Oppenheimer & Co's IBDW Position: Q1 2026 in Review

Oppenheimer & Co reduced its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 3.1% in Q1 2026, selling an estimated $31K and leaving 45,781 shares worth $958K. The position accounts for 0.01% of the portfolio, ranked #878.

Oppenheimer & Co first reported a position in IBDW in Q2 2024 and has held it in 8 quarters since. The position peaked at $999K in Q4 2025. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.

Oppenheimer & Co held 45,781 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $958K as of Q1 2026.
Oppenheimer & Co sold 1,466 iShares iBonds Dec 2031 Term Corporate ETF shares in Q1 2026, an estimated $31K.
iShares iBonds Dec 2031 Term Corporate ETF made up 0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #878 holding.
Oppenheimer & Co first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q2 2024 and has held it in 8 quarters since.
Oppenheimer & Co's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $999K in Q4 2025.
288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.